Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
Laure Gossec, Josef S Smolen, C. Gaujoux-Viala, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 1, pp. 4-12
Open Access | Times Cited: 452

Showing 26-50 of 452 citing articles:

The psychosocial burden of psoriatic arthritis
M. Elaine Husni, Joseph F. Merola, Sara Davin
Seminars in Arthritis and Rheumatism (2017) Vol. 47, Iss. 3, pp. 351-360
Open Access | Times Cited: 153
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Laura C. Coates, Oliver FitzGerald, Philip Helliwell, et al.
Seminars in Arthritis and Rheumatism (2016) Vol. 46, Iss. 3, pp. 291-304
Open Access | Times Cited: 146
A randomized, double‐blind, placebo‐controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
Alice B. Gottlieb, Richard Langley, Bruce Strober, et al.
British Journal of Dermatology (2012) Vol. 167, Iss. 3, pp. 649-657
Open Access | Times Cited: 141
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
Ashok Kumar Jha, Alex Upton, W. Dunlop, et al.
Advances in Therapy (2015) Vol. 32, Iss. 8, pp. 742-756
Open Access | Times Cited: 139
Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases
Maria Alice V. Willrich, David Murray, Melissa R. Snyder
Translational research (2014) Vol. 165, Iss. 2, pp. 270-282
Closed Access | Times Cited: 138
Burden of Disease: Psoriasis and Psoriatic Arthritis
Wolf‐­Henning Boehncke, Alan Menter
American Journal of Clinical Dermatology (2013) Vol. 14, Iss. 5, pp. 377-388
Closed Access | Times Cited: 127
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative
C. Roubille, Vincent Richer, Tara Starnino, et al.
The Journal of Rheumatology (2015) Vol. 42, Iss. 10, pp. 1767-1780
Open Access | Times Cited: 123
A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis
Brigitte Michelsen, Ragnhild Fiane, Andreas P. Diamantopoulos, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0123582-e0123582
Open Access | Times Cited: 120
Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study
K. M. Fagerli, Elisabeth Lie, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases (2013) Vol. 72, Iss. 11, pp. 1840-1844
Closed Access | Times Cited: 120
Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials
Richard Conway, Candice Low, Robert J. Coughlan, et al.
BMJ (2015) Vol. 350, Iss. mar13 17, pp. h1269-h1269
Open Access | Times Cited: 118
Clinical Characteristics, Disease Activity, and Patient‐Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Chitra Karki, Jacqueline B. Palmer, et al.
Arthritis Care & Research (2017) Vol. 69, Iss. 11, pp. 1692-1699
Open Access | Times Cited: 111
Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies
S. P. Raychaudhuri, Reason Wilken, Andrea Sukhov, et al.
Journal of Autoimmunity (2016) Vol. 76, pp. 21-37
Closed Access | Times Cited: 110
Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis
Sofía Ramiro, Josef S Smolen, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 3, pp. 490-498
Open Access | Times Cited: 109
The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease
Lihi Eder, Vinod Chandran, Dafna D. Gladman
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 11, pp. 1990-1996
Closed Access | Times Cited: 105
Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series
Andreas P. Diamantopoulos, Helene Hetland, Geirmund Myklebust
BioMed Research International (2013) Vol. 2013, pp. 1-3
Open Access | Times Cited: 102
Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases
Lesley J. Scott
Drugs (2014) Vol. 74, Iss. 12, pp. 1379-1410
Closed Access | Times Cited: 99
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial
Alvin F. Wells, Christopher J Edwards, Alan Kivitz, et al.
Lara D. Veeken (2018) Vol. 57, Iss. 7, pp. 1253-1263
Open Access | Times Cited: 91
The concept of difficult-to-treat disease in rheumatology: where next?
György Nagy, Lilla Gunkl-Tóth, András M Dorgó, et al.
The Lancet Rheumatology (2025)
Closed Access | Times Cited: 1
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease
Ignazio Olivieri, Fabrizio Cantini, Fabiana Castiglione, et al.
Autoimmunity Reviews (2014) Vol. 13, Iss. 8, pp. 822-830
Closed Access | Times Cited: 95
Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis
Daniel Wendling, Cédric Lukas, Julien Paccou, et al.
Joint Bone Spine (2014) Vol. 81, Iss. 1, pp. 6-14
Open Access | Times Cited: 93
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
Shunsuke Mori
World Journal of Gastroenterology (2015) Vol. 21, Iss. 36, pp. 10274-10274
Open Access | Times Cited: 89
Apremilast: A Review in Psoriasis and Psoriatic Arthritis
Emma D. Deeks
Drugs (2015) Vol. 75, Iss. 12, pp. 1393-1403
Closed Access | Times Cited: 87
Switching biologics in the treatment of psoriatic arthritis
Joseph F. Merola, Benjamin Lockshin, Elinor Mody
Seminars in Arthritis and Rheumatism (2017) Vol. 47, Iss. 1, pp. 29-37
Open Access | Times Cited: 83
Is There Subclinical Synovitis in Early Psoriatic Arthritis? A Clinical Comparison With Gray‐Scale and Power Doppler Ultrasound
Jane Freeston, Laura C. Coates, J. Nam, et al.
Arthritis Care & Research (2013) Vol. 66, Iss. 3, pp. 432-439
Open Access | Times Cited: 82
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Maja Bulatović Ćalasan, Oscar F. C. van den Bosch, M.C.W. Creemers, et al.
Arthritis Research & Therapy (2013) Vol. 15, Iss. 6
Open Access | Times Cited: 81

Scroll to top